美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Veradermics, Inc.

37.75

+20.75122.06%

盤後：37.12-0.6300-1.67%18:53 EST

成交量：332.07萬

成交額：1.22億

市值：12.59億

市盈率：-0.45

高：40.01

開：34.00

低：32.00

收：17.00

52周最高：40.01

52周最低：32.00

股本：3,335.02萬

流通股本：1,510.00萬

量比：- -

換手率：21.99%

股息：- -

股息率：- -

每股收益(TTM):-83.0983

每股收益(LYR):-37.0495

淨資產收益率：--

總資產收益率：--

市淨率：-12.78

市盈率(LYR):-1.02

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Veradermics, Inc.

交易所：

NYSE

成立時間：

2019

員工人數：

19

公司地址：

470 James Street,Suite 14,New Haven,Connecticut,United States

官網：

http://www.veradermics.com

郵編：

06513

電話：

傳真：

- -

簡介：

VeraDermics, Incorporated成立於2019年10月5日，最初位於德克薩斯州，後於2021年9月15日轉換為特拉華州公司。這家由皮膚科醫生創辦的晚期臨床階段生物製藥公司專註於開發針對普遍存在的美學和皮膚病狀況的創新療法。VeraDermics主要致力於解決影響美國眾多個體的模式性脫髮（PHL）治療挑戰。公司目前正在推進其主要候選藥物VDPHL01，這是一種口服非激素治療，旨在優化毛髮生長，同時最小化與傳統療法相關的副作用。VeraDermics正在進行關鍵臨床試驗，以支持監管審批，並通過其針對性的治療方法，旨在改變PHL的管理方式。

董事

名稱

職位

Reid Waldman

Chief Executive Officer and Director

David Friedman

Independent Director

Jane Grant Kels

Independent Director

John W. Childs

Independent Director

Katarina Pance

Independent Director

Patrick Enright

Independent Director

Vlad Coric

Independent Director

股東

名稱

職位

Reid Waldman

Chief Executive Officer and Director

Dominic Carrano

Chief Financial Officer

Mark Neumann

Chief Commercial and Strategy Officer

Michael V. Greco

General Counsel

Tim Durso

President

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MANE/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MANE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","market":"US","secType":"STK","nameCN":"Veradermics, Inc.","latestPrice":37.75,"timestamp":1770238800000,"preClose":17,"halted":0,"volume":3320705,"hourTrading":{"tag":"盘后","latestPrice":37.12,"preClose":37.75,"latestTime":"18:53 EST","volume":52452,"amount":1976743.732536,"timestamp":1770249233292,"change":-0.63,"changeRate":-0.016689,"amplitude":0.07894},"delay":0,"changeRate":1.2205882352941178,"floatShares":15100000,"shares":33350170,"eps":-83.09831,"marketStatus":"盤後交易","change":20.75,"latestTime":"02-04 18:56:07 EST","open":34,"high":40.01,"low":32,"amount":121605777.83135,"amplitude":0.471176,"askPrice":37.74,"askSize":33,"bidPrice":37,"bidSize":56,"shortable":3,"etf":0,"ttmEps":-83.09831,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1770253200000},"marketStatusCode":4,"adr":0,"listingDate":1770181200000,"exchange":"NYSE","adjPreClose":17,"postHourTrading":{"tag":"盘后","latestPrice":37.12,"preClose":37.75,"latestTime":"18:53 EST","volume":52452,"amount":1976743.732536,"timestamp":1770249233292,"change":-0.63,"changeRate":-0.016689,"amplitude":0.07894},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","floatShares":15100000,"roa":"--","roe":"--","lyrEps":-37.049501,"shares":33350170,"dividePrice":0,"high":40.01,"amplitude":0.471176,"preClose":17,"low":32,"week52Low":32,"pbRate":"-12.78","week52High":40.01,"institutionHeld":0,"latestPrice":37.75,"committee":0.258427,"eps":-83.09831,"divideRate":0,"volume":3320705,"delay":0,"ttmEps":-83.09831,"open":34,"prevYearClose":17,"prevWeekClose":17,"prevMonthClose":17,"prevQuarterClose":17,"fiveDayClose":17,"twentyDayClose":17,"sixtyDayClose":17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MANE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MANE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MANE\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MANE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MANE","date":"2026-02-03","current":-0.45729,"percent":1,"low":-9.296992,"twenty":-9.296992,"median":-9.296992,"eighty":-9.296992,"high":-9.296992,"avg":-9.296992,"sd":0,"marketCap":500252550},"quantilePoints":[{"date":"2026-02-03","current":-9.296992,"twenty":-9.296992,"median":-9.296992,"eighty":-9.296992,"marketCap":500252550}],"updateTime":1770230271693},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":684321879,"yearFounded":2019,"employeeNum":19,"address":"470 James Street,Suite 14,New Haven,Connecticut,United States","zipCode":"06513","officePhone":"(228) 372-3376"},"stockCompanyDetail":{"websiteUrl":"http://www.veradermics.com","compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":0.0093},{"period":"3month","weight":0.0176},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1535},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"VeraDermics, Incorporated成立於2019年10月5日，最初位於德克薩斯州，後於2021年9月15日轉換為特拉華州公司。這家由皮膚科醫生創辦的晚期臨床階段生物製藥公司專註於開發針對普遍存在的美學和皮膚病狀況的創新療法。VeraDermics主要致力於解決影響美國眾多個體的模式性脫髮（PHL）治療挑戰。公司目前正在推進其主要候選藥物VDPHL01，這是一種口服非激素治療，旨在優化毛髮生長，同時最小化與傳統療法相關的副作用。VeraDermics正在進行關鍵臨床試驗，以支持監管審批，並通過其針對性的治療方法，旨在改變PHL的管理方式。","exchange":"NYSE","name":"Veradermics, Inc.","nameEN":"Veradermics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MANE\",market:\"US\",,,undefined,":{"directors":[{"name":"Reid Waldman","position":"Chief Executive Officer and Director"},{"name":"David Friedman","position":"Independent Director"},{"name":"Jane Grant Kels","position":"Independent Director"},{"name":"John W. Childs","position":"Independent Director"},{"name":"Katarina Pance","position":"Independent Director"},{"name":"Patrick Enright","position":"Independent Director"},{"name":"Vlad Coric","position":"Independent Director"}],"executives":[{"name":"Reid Waldman","position":"Chief Executive Officer and Director"},{"name":"Dominic Carrano","position":"Chief Financial Officer"},{"name":"Mark Neumann","position":"Chief Commercial and Strategy Officer"},{"name":"Michael V. Greco","position":"General Counsel"},{"name":"Tim Durso","position":"President"}]}}}